Gamma Knife Market Worth US$ 411.0 Mn During 2015-2025

Valley Cottage, NY, June 18, 2016 --(PR.com)-- Future Market Insights (FMI) announces the release of its latest report titled, “Gamma Knife Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025.” According to the report, the global gamma knife market was valued at US$ 156.8 Mn in 2014 and is anticipated to reach US$ 411.0 Mn by 2025, registering a compound annual growth rate of 9.0% over the forecast period.

Market Drivers and Restraints

Global Gamma Knife market growth is majorly driven by a rising ageing population, increasing incidence of cancer and increasing prevalence of neurological disorders. By disease indication, brain metastasis cases undergoing Gamma Knife treatment accounts for highest market share as compared to other indications. Painless and non-invasive elective surgeries with high success rate have recently become the treatment of choice. Leading Gamma Knife manufacturers are entering into tie-ups with premium healthcare organisations in developed and emerging economies for setting up Gamma Knife surgery centres and Gamma Knife installations.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-589

However, lack of awareness about Gamma Knife treatment, negative perceptions of the radioactive elements and lack of trained professionals to operate these systems are expected to hamper market growth during the forecast period.

Market Segments

The global Gamma Knife market is segmented on the basis of indication, anatomy or organs treated and geography.

By indication type, the global Gamma Knife market is segmented into brain metastasis, cancer arteriovenous malformation (AVM), trigeminal neuralgia and others. Among these segments, brain metastasis accounted for approximately 68.5% share of the global Gamma Knife market in 2014 and is expected to dominate the market over the forecast period, exhibiting a CAGR of 9.2% between 2015 and 2025.

Cancer is the second-most prevalent indication, accounting for over 10.2% market share in 2014, and is expected to increase at a comparatively high CAGR of 10.3% during the forecast period.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-589

Trigeminal neuralgia accounted for approximately 9.8% share of the global Gamma Knife market in 2014 and is expected to further gain share at a comparatively high CAGR of 7% during the forecast period. Arteriovenous malformation and others contribute around 11.3% of the global Gamma Knife market revenue.

On the bases of anatomy, the global Gamma Knife market is segmented into head, neck and other body parts.

Head segment accounted for approximately 88.1% global market share in 2014 and is expected to dominate the global Gamma Knife market throughout the forecast period, exhibiting a CAGR of 9.2% between 2015 and 2025.

Neck segment accounted for over 7.8% share of the global market in 2014, which is expected to increase at a CAGR of 7.7%, during the forecast period. However, scope for Gamma Knife treatment for other body parts is expected to expand in future due to market expansion and innovations in techniques.

Ask The Analyst@ http://www.futuremarketinsights.com/askus/rep-gb-589

On the basis of region, North America dominated the global Gamma Knife market at 29% in terms of revenue in 2014. However, Europe, Asia Pacific, Latin America and MEA are projected to witness relatively high CAGRs of 7.7%, 10.5%, 11.1% and 11.7%, respectively over the forecast period.

Competitive Landscape

Key players in the global Gamma Knife market include Elekta AB, Varian Medical Systems, Inc. and Huiheng Medical, Inc.